These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Brief Report: Systemic Inflammation, Immune Activation, and Impaired Lung Function Among People Living With HIV in Rural Uganda. North CM; Muyanja D; Kakuhikire B; Tsai AC; Tracy RP; Hunt PW; Kwon DS; Christiani DC; Okello S; Siedner MJ J Acquir Immune Defic Syndr; 2018 Aug; 78(5):543-548. PubMed ID: 29683991 [TBL] [Abstract][Full Text] [Related]
25. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. Wilson EM; Singh A; Hullsiek KH; Gibson D; Henry WK; Lichtenstein K; Önen NF; Kojic E; Patel P; Brooks JT; Sereti I; Baker JV; J Infect Dis; 2014 Nov; 210(9):1396-406. PubMed ID: 24813472 [TBL] [Abstract][Full Text] [Related]
26. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease. Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048 [TBL] [Abstract][Full Text] [Related]
27. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels. Davis BH; Zarev PV Cytometry B Clin Cytom; 2005 Jan; 63(1):16-22. PubMed ID: 15624200 [TBL] [Abstract][Full Text] [Related]
28. Macrophage markers soluble CD163 and soluble mannose receptor are associated with liver injury in patients with paracetamol overdose. Siggaard CB; Kazankov K; Rødgaard-Hansen S; Møller HJ; Donnelly MC; Simpson KJ; Grønbaek H Scand J Gastroenterol; 2019 May; 54(5):623-632. PubMed ID: 31067143 [TBL] [Abstract][Full Text] [Related]
29. Monocyte Activation Is Associated With Worse Cognitive Performance in HIV-Infected Women With Virologic Suppression. Imp BM; Rubin LH; Tien PC; Plankey MW; Golub ET; French AL; Valcour VG J Infect Dis; 2017 Jan; 215(1):114-121. PubMed ID: 27789726 [TBL] [Abstract][Full Text] [Related]
30. Normalization of Soluble CD163 Levels After Institution of Antiretroviral Therapy During Acute HIV Infection Tracks with Fewer Neurological Abnormalities. D'Antoni ML; Byron MM; Chan P; Sailasuta N; Sacdalan C; Sithinamsuwan P; Tipsuk S; Pinyakorn S; Kroon E; Slike BM; Krebs SJ; Khadka VS; Chalermchai T; Kallianpur KJ; Robb M; Spudich S; Valcour V; Ananworanich J; Ndhlovu LC; J Infect Dis; 2018 Sep; 218(9):1453-1463. PubMed ID: 29868826 [TBL] [Abstract][Full Text] [Related]
31. The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients. Dultz G; Gerber L; Zeuzem S; Sarrazin C; Waidmann O J Viral Hepat; 2016 Apr; 23(4):267-73. PubMed ID: 26554542 [TBL] [Abstract][Full Text] [Related]
32. Single-centre experience of the macrophage activation marker soluble (s)CD163 - associations with disease activity and treatment response in patients with autoimmune hepatitis. Grønbaek H; Kreutzfeldt M; Kazankov K; Jessen N; Sandahl T; Hamilton-Dutoit S; Vilstrup H; J Møller H Aliment Pharmacol Ther; 2016 Nov; 44(10):1062-1070. PubMed ID: 27679428 [TBL] [Abstract][Full Text] [Related]
33. Higher levels of circulating monocyte-platelet aggregates are correlated with viremia and increased sCD163 levels in HIV-1 infection. Liang H; Duan Z; Li D; Li D; Wang Z; Ren L; Shen T; Shao Y Cell Mol Immunol; 2015 Jul; 12(4):435-43. PubMed ID: 25109683 [TBL] [Abstract][Full Text] [Related]
34. Utility of Macrophage-activated Marker CD163 for Diagnosis and Prognosis in Pulmonary Tuberculosis. Suzuki Y; Shirai M; Asada K; Miwa S; Karayama M; Nakamura Y; Inui N; Shirai T; Hayakawa H; Baba S; Suda T Ann Am Thorac Soc; 2017 Jan; 14(1):57-64. PubMed ID: 27684274 [TBL] [Abstract][Full Text] [Related]
35. Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus. Dultz G; Gerber L; Farnik H; Berger A; Vermehren J; Pleli T; Zeuzem S; Piiper A; Kronenberger B; Waidmann O J Viral Hepat; 2015 Apr; 22(4):427-32. PubMed ID: 25181653 [TBL] [Abstract][Full Text] [Related]
36. HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana. Mosepele M; Mohammed T; Mupfumi L; Moyo S; Bennett K; Lockman S; Hemphill LC; Triant VA Cardiovasc J Afr; 2018 May/Jun 23; 29(3):155-161. PubMed ID: 29771268 [TBL] [Abstract][Full Text] [Related]
37. Soluble CD163 is associated with body mass index and blood pressure in hypertensive obese Saudi patients. Al-Daghri NM; Al-Attas OS; Bindahman LS; Alokail MS; Alkharfy KM; Draz HM; Yakout S; McTernan PG; Sabico S; Chrousos GP Eur J Clin Invest; 2012 Nov; 42(11):1221-6. PubMed ID: 22946776 [TBL] [Abstract][Full Text] [Related]
38. Soluble CD14, CD163, and CD27 biomarkers distinguish ART-suppressed youth living with HIV from healthy controls. Williams JC; Zhang X; Karki M; Chi YY; Wallet SM; Rudy BJ; Nichols SL; Goodenow MM; Sleasman JW J Leukoc Biol; 2018 Apr; 103(4):671-680. PubMed ID: 29377283 [TBL] [Abstract][Full Text] [Related]
39. Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors. Castley A; Williams L; James I; Guelfi G; Berry C; Nolan D PLoS One; 2016; 11(6):e0158169. PubMed ID: 27355513 [TBL] [Abstract][Full Text] [Related]
40. Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection. Tornai T; Vitalis Z; Sipeki N; Dinya T; Tornai D; Antal-Szalmas P; Karanyi Z; Tornai I; Papp M Liver Int; 2016 Nov; 36(11):1628-1638. PubMed ID: 27031405 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]